Aethon Therapeutics
New York, US · Founded 2022 · Delaware corporation · 16 employees on LinkedIn
Find your way into Aethon Therapeutics
Sign up to see every warm intro you have to Aethon Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aethon Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ATP develops early-stage life sciences companies, focused on building new biotechnology ventures.
Founders & leadership
WE
William EngelsNamed on SEC filing
Board
Reported raises · per SEC filings
Form D private placements$6M disclosed across 1 round · 2022
▶$6MraisedDec 2022 · 2 investors · BiotechnologyRule 506(b)
▶$6MraisedDec 2022 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William EngelsExecutive Officer
- Seth HarrisonDirector
- Paul Da Silva JardineExecutive Officer, Director
- Rajesh ChopraExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $6M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Aethon Therapeutics do?
- ATP develops early-stage life sciences companies, focused on building new biotechnology ventures.
- How much funding has Aethon Therapeutics raised?
- Aethon Therapeutics has disclosed $6M raised across 1 round.
- Where is Aethon Therapeutics headquartered?
- Aethon Therapeutics is headquartered in New York, US.